IVIG is a sterile solution of antibodies collected from healthy donors, which is administered through the veins into the body. Currently, the immunoglobulin industry is growing on account of increasing FDA/EMA approvals and government support. IVIG usage against the conditions within the criteria (i.e. FDA/EMA approved indications) have increased greatly and the largest increase found in Chronic Inflammatory demyelinating polyneuropathy (CIDP), Hypogammaglobulinemia and immunodeficiency diseases. In addition, there has been a substantial increase in IVIG prescriptions for the treatment of off-label indications, such as, specific antibody deficiency, Guillain-Barre syndrome, Inflammatory Myopathies and others. However, factors such as the high cost of IVIG treatment, side effects associated with use of IVIG, stringent government regulations and a lengthy product approval process would hamper its market growth. Despite several challenges such as inadequate supply of immunoglobulins, stringent regulatory policies and the high cost associated with IVIG treatments, the global IVIG market would witness notable growth during the forecast period.
Global IVIG market is segmented based on its types, application and geography. The application segment includes Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency diseases, Congenital AIDS, Chronic Lymphocytic Leukaemia (CLL), Myasthenia Gravis, Multifocal motor neuropathy, Idiopathic thrombocytopenic purpura (ITP), Kawasaki disease, Guillain-Barre syndrome, and others. Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP) holds a dominant share in the market due to a large patient population and the unavailability of effective alternatives for IVIG treatment. Geographically, the report covers five key regions, North America, Europe, Asia Pacific, and LAMEA. Presently, North America occupies a majority of the market followed by the Asia Pacific region. High adoption of IVIG therapies and a large pool of patient population in the North American region is a prime factor responsible for the growth of the North America IVIG market. However, in the Asia-pacific region, growing awareness for immunodeficiency disease & neurological disorders along with the increasing preference towards IVIG therapies, largely drives the market. The companies profiled in this report include Baxter international Inc., CSL Limited, Grifols S.A, Octapharma Ag, Kedrion Pharma, LFB group, Biotest AG, china Biologics products Ltd, Bayer Healthcare, and others.
KEY MARKET SEGMENT:
Global IVIG market is segmented based on the application, types and geography
MARKET BY APPLICATION
MARKET BY TYPE
MARKET BY GEOGRAPHY
SIMILAR MARKET STUDIES
The 2017-2022 Bio Pharma Buffer Report on Global and United States Market, Status and Forecast, by Players, Types and Applications is a professional and in-depth study on the current state of the Bio Pharma Buffer market. Annual estimates and forecasts are provided for the period 2017 through 2022. Also, a ...
September 2017 | $2960 | View Details >>
In the last several years, China market of Vitamin D Testing developed rapidly, with an average growth rate of 17.90%. In 2016, China Revenue of Vitamin D Testing is nearly 80.68 M USD, will continue growth at 16.01% in 2022 the market of Vitamin D Testing will at 196.66 M ...
September 2017 | $3200 | View Details >>
Currently, some companies in the world can produce Artificial Tear product, mainly concentrating in North America. The main market players are Allergan, Alcon (Novartis), Bausch & Lomb, Abbott, Santen Pharmaceutical, Ursapharm Rohto, etc. The sales volume of Artificial Tear in EMEA increased from 141.16 Million Unit in 2012 to 203.70 ...
September 2017 | $4000 | View Details >>
This report studies the Cardiac Care Medical Equipment market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Cardiac Care Medical Equipment market by product type and ...
September 2017 | $2900 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research